8-K: Replimune Group Hosts Investor Day, Makes Presentation Materials Publicly Available

Replimune Group, Inc. announced it hosted an Investor Day on June 24, 2025, making the presentation and webcast available online for investor review.

Summary

• Replimune Group, Inc. (the "Company") held an Investor Day on Tuesday, June 24, 2025, at 10:00 a.m. ET.
• The audio webcast and accompanying updated investor event presentation deck are now accessible under the "Events and Presentations" section of the Company's website at www.replimune.com.
• This Form 8-K serves as a Regulation FD disclosure to ensure the information shared during the Investor Day is publicly available.
• The Company reiterates its policy of using its corporate website as a primary channel for disclosing material non-public information and complying with Regulation FD obligations.

Sentiment

Score: 5

Explanation: The document is a standard procedural filing announcing an Investor Day and the availability of related materials, containing no new financial or operational information directly within the 8-K itself, thus maintaining a neutral sentiment.

Positives

• The Company hosted an Investor Day, demonstrating a commitment to transparency and providing updates to investors.
• Materials from the Investor Day, including the audio webcast and presentation deck, are readily available on the Company's website, facilitating investor access to information.

Risks

• Information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, limiting liability under that section.
• The information is not deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly stated by specific reference in such filing.

Future Outlook

The document refers to an Investor Day where forward-looking statements and guidance are likely to have been provided, with the webcast and presentation materials available on the company's website for detailed review.

Management Comments

• "Replimune Group, Inc. intends to use its website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD."

Industry Context

The filing itself does not provide specific industry context beyond the company's general operations as a biotechnology firm, focusing instead on a procedural disclosure related to an investor event.

Stakeholder Impact

• Shareholders and investment professionals are provided with access to updated investor information and strategic insights via the Investor Day materials, enabling more informed decision-making.

Next Steps

• Investors are advised to monitor the Company's website (www.replimune.com) for the audio webcast and presentation deck from the Investor Day.
• Investors should continue to follow the Company's press releases, SEC filings, and public conference calls and webcasts for future disclosures.

Key Dates

Keywords

Replimune, Investor Day, SEC filing, 8-K, Regulation FD, Biotechnology, Investor Relations, Corporate Disclosure